Related Experiment Video

Updated: Apr 28, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.9K

Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy

Kirsteen M Tullett1, Mireille H Lahoud2, Kristen J Radford3

  • 1Mater Research Institute, University of Queensland , Brisbane, QLD , Australia ; School of Medicine, University of Queensland , Brisbane, QLD , Australia ; Centre for Biomedical Research, Burnet Institute , Melbourne, VIC , Australia.

Frontiers in Immunology
|June 7, 2014
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Clec9ADC targetingXCR1cross-presentationdendritic cellsimmunotherapy

More Related Videos

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.0K
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

10.3K

Related Concept Videos